Invesco Ltd. Sells 51,134 Shares of Liquidia Technologies, Inc. $LQDA

Invesco Ltd. reduced its position in shares of Liquidia Technologies, Inc. (NASDAQ:LQDA) by 7.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 649,037 shares of the company’s stock after selling 51,134 shares during the period. Invesco Ltd. owned approximately 0.76% of Liquidia Technologies worth $9,573,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. Whitefort Capital Management LP lifted its holdings in Liquidia Technologies by 16.8% during the 4th quarter. Whitefort Capital Management LP now owns 1,987,245 shares of the company’s stock worth $23,370,000 after purchasing an additional 285,220 shares during the last quarter. Vestal Point Capital LP lifted its holdings in Liquidia Technologies by 17.3% during the 4th quarter. Vestal Point Capital LP now owns 1,760,000 shares of the company’s stock worth $20,698,000 after purchasing an additional 260,000 shares during the last quarter. Tang Capital Management LLC lifted its holdings in Liquidia Technologies by 37.5% during the 4th quarter. Tang Capital Management LLC now owns 1,100,000 shares of the company’s stock worth $12,936,000 after purchasing an additional 300,000 shares during the last quarter. Northern Trust Corp lifted its holdings in Liquidia Technologies by 19.5% during the 4th quarter. Northern Trust Corp now owns 589,921 shares of the company’s stock worth $6,937,000 after purchasing an additional 96,381 shares during the last quarter. Finally, Janus Henderson Group PLC lifted its holdings in Liquidia Technologies by 1,484.5% during the 4th quarter. Janus Henderson Group PLC now owns 535,552 shares of the company’s stock worth $6,293,000 after purchasing an additional 501,752 shares during the last quarter. 64.54% of the stock is owned by institutional investors and hedge funds.

Liquidia Technologies Price Performance

Shares of NASDAQ LQDA opened at $26.84 on Monday. The stock has a market capitalization of $2.31 billion, a PE ratio of -15.79 and a beta of 0.14. The company has a debt-to-equity ratio of 9.84, a current ratio of 2.49 and a quick ratio of 2.41. The business has a fifty day moving average price of $17.51 and a two-hundred day moving average price of $15.96. Liquidia Technologies, Inc. has a fifty-two week low of $8.75 and a fifty-two week high of $28.00.

Liquidia Technologies (NASDAQ:LQDA) last posted its quarterly earnings results on Tuesday, August 12th. The company reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.43) by ($0.06). Liquidia Technologies had a negative return on equity of 232.96% and a negative net margin of 732.17%.The business had revenue of $8.84 million for the quarter, compared to analyst estimates of $3.90 million. Liquidia Technologies’s quarterly revenue was up 141.5% on a year-over-year basis. As a group, equities analysts predict that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current fiscal year.

Insider Activity at Liquidia Technologies

In other news, CFO Michael Kaseta sold 30,000 shares of the business’s stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $20.00, for a total transaction of $600,000.00. Following the completion of the transaction, the chief financial officer owned 376,412 shares of the company’s stock, valued at approximately $7,528,240. The trade was a 7.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Roger Jeffs sold 20,252 shares of the business’s stock in a transaction on Monday, July 14th. The stock was sold at an average price of $14.28, for a total value of $289,198.56. Following the transaction, the chief executive officer directly owned 1,038,560 shares of the company’s stock, valued at $14,830,636.80. This trade represents a 1.91% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 90,277 shares of company stock worth $1,469,392 in the last three months. Insiders own 30.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on LQDA. Needham & Company LLC lifted their price target on Liquidia Technologies from $32.00 to $36.00 and gave the stock a “buy” rating in a report on Tuesday, August 12th. Oppenheimer set a $13.00 price target on Liquidia Technologies and gave the stock an “underperform” rating in a report on Monday, May 19th. Bank of America dropped their price objective on Liquidia Technologies from $25.00 to $23.00 and set a “buy” rating for the company in a report on Wednesday, June 11th. HC Wainwright lifted their price objective on Liquidia Technologies from $29.00 to $35.00 and gave the company a “buy” rating in a report on Wednesday, May 28th. Finally, BTIG Research reaffirmed a “buy” rating on shares of Liquidia Technologies in a report on Tuesday, May 27th. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $32.11.

Liquidia Technologies Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).